Chuncheon Sacred Heart hospital
Chuncheon, Gangwon-do, 200-704, South Korea
NCT Number: NCT01944878
The aim of this study is to assess the role of portal hypertension of peptic ulcer disease in liver cirrhosis and chronic hepatitis.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Chuncheon, Gangwon-do, 200-704, South Korea
Retrospective case-control study
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Retrospective case-control study (from 2009 to 2012, up to 3 years)
The association of hepatic vein pressure gradient that reflects portal hypertension and peptic ulcer disease in patients with liver cirrhosis was assessed statistically.
(NO specific time frame, only confined to 2009 to 2012, when the HVPG measurement was done). The Mann-Whitney test was used to evaluate the association between PUD or not and HVPG degree, by SPSS software.
Time frame: Retrospective case-control study (from 2009 to 2012, up to 3 years)
Chuncheon Sacred Heart Hospital
Other
Retrospective Observational Study of Impact of Portal Hypertension for the Peptic Ulcer in Liver Cirrhosis and Chronic Hepatitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05118308
Chronic Liver Disease, Cirrhosis
Montreal, Quebec, Canada
View Trial DetailsNCT01072721
Cholestasis of Parenteral Nutrition, Cirrhosis
Paris, France
View Trial DetailsNCT03438916
Cirrhosis, Digestive System Diseases
Hvidovre, Denmark
View Trial DetailsNCT01851252
Bleeding, Chronic Liver Disease
Haifa, Israel
View Trial Details